Literature DB >> 17635797

Rheumatic fever and rheumatic heart disease: genetics and pathogenesis.

L Guilherme1, R Ramasawmy, J Kalil.   

Abstract

Molecular mimicry between streptococcal and human proteins is considered as the triggering factor leading to autoimmunity in rheumatic fever (RF) and rheumatic heart disease (RHD). Here, we present a review of the genetic susceptibility markers involved in the development of RF/RHD and the major immunopathological events underlying the pathogenesis of RF and RHD. Several human leucocyte antigen (HLA) class II alleles are associated with the disease. Among these alleles, HLA-DR7 is predominantly observed in different ethnicities and is associated with the development of valvular lesions in RHD patients. Cardiac myosin is one of the major autoantigens involved in rheumatic heart lesions and several peptides from the LMM (light meromyosin) region were recognized by peripheral and intralesional T-cell clones from RF and RHD patients. The production of TNF-alpha and IFN-gamma from heart-infiltrating mononuclear cells suggests that Th-1 type cytokines are the mediators of RHD heart lesions while the presence of few interleukin-4 producing cells in the valve tissue contributes to the maintenance and progression of the valvular lesions.

Entities:  

Mesh:

Year:  2007        PMID: 17635797     DOI: 10.1111/j.1365-3083.2007.01974.x

Source DB:  PubMed          Journal:  Scand J Immunol        ISSN: 0300-9475            Impact factor:   3.487


  31 in total

Review 1.  Understanding rheumatic fever.

Authors:  Pedro Ming Azevedo; Rosa Rodrigues Pereira; Luiza Guilherme
Journal:  Rheumatol Int       Date:  2011-09-28       Impact factor: 2.631

Review 2.  Valvular heart diseases in the developing world: developmental biology takes center stage.

Authors:  Emily J Farrar; Jonathan T Butcher
Journal:  J Heart Valve Dis       Date:  2012-03

3.  Mediterranean fever (MEFV) gene mutation frequency is not increased in adults with rheumatic heart disease.

Authors:  Ismail Simsek; Cem Koz; Nurcan Basar; Ismail Sari; Hakan Erdem; Salih Pay; Bunyamin Kisacik; Muhterem Bahce; Ayhan Dinc
Journal:  Clin Rheumatol       Date:  2010-07-20       Impact factor: 2.980

4.  Echocardiographic screening for rheumatic heart disease.

Authors:  Eloi Marijon; Phalla Ou; David S Celermajer; Beatriz Ferreira; Ana Olga Mocumbi; Daniel Sidi; Xavier Jouven
Journal:  Bull World Health Organ       Date:  2008-02       Impact factor: 9.408

Review 5.  T cell subsets: an integral component in pathogenesis of rheumatic heart disease.

Authors:  Devinder Toor; Neha Sharma
Journal:  Immunol Res       Date:  2018-02       Impact factor: 2.829

Review 6.  Molecular Mimicry, Autoimmunity, and Infection: The Cross-Reactive Antigens of Group A Streptococci and their Sequelae.

Authors:  Madeleine W Cunningham
Journal:  Microbiol Spectr       Date:  2019-07

7.  A GMCSF-neuroantigen fusion protein is a potent tolerogen in experimental autoimmune encephalomyelitis (EAE) that is associated with efficient targeting of neuroantigen to APC.

Authors:  J Lori Blanchfield; Mark D Mannie
Journal:  J Leukoc Biol       Date:  2010-03       Impact factor: 4.962

8.  The influence of persistent pathogens on circulating levels of inflammatory markers: a cross-sectional analysis from the Multi-Ethnic Study of Atherosclerosis.

Authors:  Aydin Nazmi; Ana V Diez-Roux; Nancy S Jenny; Michael Y Tsai; Moyses Szklo; Allison E Aiello
Journal:  BMC Public Health       Date:  2010-11-17       Impact factor: 3.295

9.  Synergistic effects of cyclic strain and Th1-like cytokines on tenascin-C production by rheumatic aortic valve interstitial cells.

Authors:  L Jiang; X F Wei; D H Yi; P Xu; H Liu; Q Chang; S M Yang; Z F Li; H B Gao; G J Hao
Journal:  Clin Exp Immunol       Date:  2008-11-20       Impact factor: 4.330

10.  Critical role of glycosylation in determining the length and structure of T cell epitopes.

Authors:  Tamás G Szabó; Robin Palotai; Péter Antal; Itay Tokatly; László Tóthfalusi; Ole Lund; György Nagy; András Falus; Edit I Buzás
Journal:  Immunome Res       Date:  2009-09-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.